[{"Assets_0_Q2_USD":73952000.0,"CommonStockSharesOutstanding_0_Q2_shares":41415796.0,"NetIncomeLoss_1_Q2_USD":-9645000.0,"NetIncomeLoss_2_Q2_USD":-19771000.0,"StockholdersEquity_0_Q2_USD":55213000.0,"Ticker":"FATE","CIK":"1434316","name":"FATE THERAPEUTICS INC","OfficialName":"Fate Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3545646272.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170814"}]